[ad_1] Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA Technology to target new variants of Covid-19 that are behind the country’s current outbreak. [ad_2] Source link
Tag: Pfizer
Drugmakers Spent Freely in 2022 to Protect Revenue
[ad_1] Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics. [ad_2] Source link
Amgen Hunts for New Revenue in $28 Billion Deal
[ad_1] Health The purchase of Horizon brings in rare-disease drugs with billions of dollars in sales that could offset revenue drops from patent expiries [ad_2] Source link
Opinion | China’s Let-It-Rip Covid Reopening
[ad_1] Opinion Commentary Xi Jinping compounds his zero-Covid mistake with a 180-degree reversal that endangers everyone. [ad_2] Source link